PIZOTIFEN (BC-105): A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND ITS THERAPEUTIC EFFICACY IN VASCULAR HEADACHES = PIZOTIFENE (BC-105): UNE REVUE DE SES PROPRIETES PHARMACOLOGIQUES ET DE SON EFFICACITE THERAPEUTIQUE DANS LES MAUX DE TETE VASCULAIRES1972; DRUGS; SWITZ.; DA. 1972; VOL. 3; NO 3-4; PP. 159-203; BIBL. 2 P.Serial Issue

PLEURAL EFFUSION AND FIBROSIS SECONDARY TO SANSERT ADMINISTRATIONDUNN JM; SLOAN H.1973; ANN. THORAC. SURG.; U.S.A.; DA. 1973; VOL. 15; NO 3; PP. 295-298; BIBL. 9REF.Serial Issue

ZUR KLINISCHEN WIRKUNG UND INDIKATION VON ADRENOCHROMDERIVATEN = EFFET CLINIQUE ET INDICATIONS DES DERIVES DE L'ADRENOCHROMEWIEGERSHAUSEN B; RIETHLING AK.1973; ZBL. PHARM. PHARMAKOTHERAP. LAB.-DIAGNOST.; DTSCH.; DA. 1973; VOL. 112; NO 1; PP. 3-8; ABS. ANGL. RUSSE; BIBL. 2P.Serial Issue

L'EVOLUTION DES FIBROSES RETROPERITONEALES DUES AU METHYSERGIDESCHRUB JC; WOLF LM; COURTOIS H et al.1973; NOUV. PRESSE MED.; FR.; DA. 1973; VOL. 2; NO 8; PP. 487-491; ABS. ANGL.; BIBL. 25 REF.Serial Issue

ERGOTAMINE AND METHYSERGIDE ABUSE IN PATIENTS WITH MIGRAINELUCAS RN; FALKOWSKI W.1973; BRIT. J. PSYCHIATRY; G.B.; DA. 1973; VOL. 122; NO 567; PP. 199-203; BIBL. 19 REF.Serial Issue

PHARMACOLOGY OF MIGRAINERASKIN NH.1981; ANNU. REV. PHARMACOL. TOXICOL.; USA; DA. 1981; VOL. 21; PP. 463-478; BIBL. 119 REF.Article

CURRENT CONCEPTS IN THE PATHOGENESIS AND INTERVAL TREATMENT OF MIGRAINE = CONCEPTS COURANTS DANS LA PATHOGENESE ET LE TRAITEMENT SEQUENTIEL DE LA MIGRAINE1972; DRUGS; SWITZ.; DA. 1972; VOL. 3; NO 3-4; PP. 153-158; BIBL. 11 REF.Serial Issue

KLINISCHE ERFAHRUNGEN MIT EINEM NEUEN MIGRAENE-PRAEPARAT HM72 (MIGRAEFLUX) = ESSAIS CLINIQUES D'UN NOUVEL ANTIMIGRAINEUX, LE HM72 (MIGRAEFLUX)BEYER D.1975; MUENCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 117; NO 17; PP. 733-734; BIBL. 7REF.Article

LISURIDE IN CLUSTER HEADACHERAFFAELLI E JR; MARTINS OJ; DOS SANTOS P DAGUA AF et al.1983; HEADACHE; ISSN 0017-8748; USA; DA. 1983; VOL. 28; NO 3; PP. 117-121; BIBL. 15 REF.Article

SPASMEN DER MUSKULAEREN STAMMARTERIEN DER EXTREMITAETEN NACH EINNAHME VON ERGOTAMINTARTRAT-HALTIGEN MEDIKAMENTEN = SPASMES ARTERIELS DES MEMBRES APRES ABSORPTION DE MEDICAMENTS CONTENANT DU TARTRATE D'ERGOTAMINEBOLLINGER A; PRETER B.1973; DTSCHE MED. WSCHR.; DTSCH.; DA. 1973; VOL. 98; NO 16; PP. 825-829; H.T. 1; ABS. ANGL.; BIBL. 24REF.Serial Issue

ERGOTAMINE AND DIHYDROERGOTAMINE ENHANCE GUANYLATE CYCLASE ACTIVITYVESELY DL.1983; RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY; ISSN 0034-5164; USA; DA. 1983; VOL. 40; NO 2; PP. 245-254; BIBL. 2 P.Article

UNE ARTERITE MESENTERIQUE DISTALE. COMPLICATION RARE DU TRAITEMENT PAR LE D. METHYLSERGIDEUTZMANN O; BARRET F; CASSAN P et al.1981; J. RADIOL.; ISSN 0242-3081; FRA; DA. 1981; VOL. 62; NO 4; PP. 257-261; ABS. ENG; BIBL. 22 REF.Article

COMPARATIVE TRIAL OF TENORMIN (ATENOLOL) AND INDERAL (PROPANOLOL) IN MIGRAINESTENSRUD P; SJAASTAD O.1980; UPS. J. MED. SCI., SUPPL.; ISSN 0300-9726; SWE; DA. 1980; NO 31; PP. 37-40; BIBL. 16 REF.Article

LOCAL REGULATION OF SUBCUTANEOUS BLOOD FLOW IN NORMAL SUBJECTS AND IN MIGRAINE PATIENTS BEFORE AND AFTER SINGLE-DOSE ERGOTAMINE TARTRATEEICKHOFF JH; TFELT HANSEN P.1982; CLIN. PHYSIOL. (OXF.); GBR; DA. 1982; VOL. 2; NO 1; PP. 29-38; BIBL. 26 REF.Article

THE ANTI-MIGRAINOUS PHARMACOLOGY OF FLUNARIZINE (R14 950), A CALCIUM ANTAGONISTAMERY WK; WAUQUIER A; VAN NUETEN JM et al.1981; DRUGS EXP. CLIN. RES.; ISSN 0378-6501; CHE; DA. 1981; VOL. 7; NO 1; PP. 1-10; BIBL. 38 REF.Article

A DOUBLE-BLIND PLACEBO-CONTROLLED PROPHYLACTIC STUDY OF FLUNARIZINE (SIBELIUM^REG.) IN MIGRAINELOUIS P.1981; HEADACHE; ISSN 0017-8748; USA; DA. 1981; VOL. 21; NO 6; PP. 235-239; BIBL. 5 REF.Article

BIOAVAILABILITY AND ANTIMIGRAINE EFFICACY OF EFFERVESCENT ERGOTAMINEALA HURULA V.1982; HEADACHE; ISSN 0017-8748; USA; DA. 1982; VOL. 22; NO 4; PP. 167-170; BIBL. 18 REF.Article

Antimigraineux = Antimigraine agentsRASCOL, A; FANCHAMPS, A.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 44-45, pp 3137-3161, issn 0037-1777Article

Clinical effects and mechanism of action of sumatriptan in migraineFERRARI, M. D; SAXENA, P. R. S.Clinical neurology and neurosurgery. 1992, Vol 94, pp S73-S77, issn 0303-8467, SUPConference Paper

Psychoactive properties of methysergideWILCOX, J. A.Journal of psychoactive drugs. 1987, Vol 19, Num 4, pp 387-388, issn 0279-1072Article

The calcium antagonist properties of cyproheptadine: implications for antimigraine actionPEROUTKA, S. J; ALLEN, G. S.Neurology. 1984, Vol 34, Num 3, pp 304-309, issn 0028-3878Article

Acetaminophen (Paracetamol)TWYCROSS, Robert; PACE, Victor; MIHALYO, Mary et al.Journal of pain and symptom management. 2013, Vol 46, Num 5, pp 747-755, issn 0885-3924, 9 p.Article

Enhanced Paracetamol Clearance with Molecular Adsorbents Recirculating System (MARS®) in Severe AutointoxicationDE GEUS, Hilde; MATHOT, Ron; VAN DER HOVEN, Ben et al.Blood purification. 2010, Vol 30, Num 2, pp 118-119, issn 0253-5068, 2 p.Article

Changing Winds: Practice Implications of Acetaminophen RegulationsROGALSKI, Andrew L; SMITH, Kelly M.Orthopedics (Thorofare). 2009, Vol 32, Num 10, pp 746-750, issn 0147-7447, 5 p.Article

Peri-operative use of paracetamolOSCIER, C. D; MILNER, Q. J. W.Anaesthesia. 2009, Vol 64, Num 1, pp 65-72, issn 0003-2409, 8 p.Article